Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush
Health Policy and Planning · 03.06.2024 · 39 (6) · 583-592
DOI: 10.1093/heapol/czae024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Policy and Planning, online erschienen am 03.04.2024. Verfasst von Emma Clarke-Deelder und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA 02115, United States. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Immunization Programs, Vaccination Coverage. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation, Grant.
Abstract (Originalsprache)
Many children do not receive a full schedule of childhood vaccines, yet there is limited evidence on the cost-effectiveness of strategies for improving vaccination coverage. Evidence is even scarcer on the cost-effectiveness of strategies for reaching ‘zero-dose children’, who have not received any routine vaccines. We evaluated the cost-effectiveness of periodic intensification of routine immunization (PIRI), a widely applied strategy for increasing vaccination coverage. We focused on Intensified Mission Indradhanush (IMI), a large-scale PIRI intervention implemented in India in 2017–2018. In 40 sampled districts, we measured the incremental economic cost of IMI using primary data, and used controlled interrupted time-series regression to estimate the incremental vaccination doses delivered. We estimated deaths and disability-adjusted life years (DALYs) averted using the Lives Saved Tool and reported cost-effectiveness from immunization programme and societal perspectives. We found that, in sampled districts, IMI had an estimated incremental cost of 2021US$13.7 (95% uncertainty interval: 10.6 to 17.4) million from an immunization programme perspective and increased vaccine delivery by an estimated 2.2 (−0.5 to 4.8) million doses over a 12-month period, averting an estimated 1413 (−350 to 3129) deaths. The incremental cost from a programme perspective was $6.21 per dose ($2.80 to dominated), $82.99 per zero-dose child reached ($39.85 to dominated), $327.63 ($147.65 to dominated) per DALY averted, $360.72 ($162.56 to dominated) per life-year saved and $9701.35 ($4372.01 to dominated) per under-5 death averted. At a cost-effectiveness threshold of 1× per-capita GDP per DALY averted, IMI was estimated to be cost-effective with 90% probability. This evidence suggests IMI was both impactful and cost-effective for improving vaccination coverage, though there is a high degree of uncertainty in the results. As vaccination programmes expand coverage, unit costs may increase due to the higher costs of reaching currently unvaccinated children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA 02115, United States.
- Department of Epidemiology and Public Health, Swiss Tropical & Public Health Institute, Allschwil 4123, Switzerland.
- University of Basel, Basel 4001, Switzerland.
- Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, MA 02115, United States.
- Management Sciences for Health, Medford, MA 02155, United States.
- Research Department, George Institute for Global Health, New Delhi, Delhi 110025, India.
ORCID-Profile: Emma Clarke-Deelder, Susmita Chatterjee, Allison Portnoy, Nicolas A Menzies
Förderung
- Bill & Melinda Gates Foundation, Grant
Zitieren
APA
Clarke-Deelder, E., Suharlim, C., Chatterjee, S., Portnoy, A., Brenzel, L., Ray, A., Cohen, J. L., Menzies, N. A., & Resch, S. C. (2024). Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush. Health Policy and Planning, 39(6), 583-592. https://doi.org/10.1093/heapol/czae024
Vancouver
Clarke-Deelder E, Suharlim C, Chatterjee S, Portnoy A, Brenzel L, Ray A, et al. Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush. Health Policy and Planning. 2024;39(6):583-592. doi:10.1093/heapol/czae024
BibTeX
@article{ClarkeDeelder2024,
author = {Clarke-Deelder, Emma and Suharlim, Christian and Chatterjee, Susmita and Portnoy, Allison and Brenzel, Logan and Ray, Arindam and Cohen, Jessica L and Menzies, Nicolas A and Resch, Stephen C},
title = {Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush},
journal = {Health Policy and Planning},
year = {2024},
volume = {39},
number = {6},
pages = {583--592},
doi = {10.1093/heapol/czae024}
}
EUVIMED